Scanlan; Matthew

Patent Applications and Registrations

Patent applications and USPTO patent grants for Scanlan; Matthew.The latest application filed is for "method for inducing cell lysis with immunogenic portions of ny-eso-1 protein".

Company Profile

0.20.15

Scanlan; Matthew - New York NY
Scanlan; Matthew - Princeton Junction NJ
Scanlan; Matthew - Princeton Juction NJ
Scanlan; Matthew - NY NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein Grant 8,541,202 - Knuth , et al. September 24, 2	2013-09-24
A34 and A33-like 3 DNA protein, antibodies thereto and methods of treatment using same Grant 8,440,807 - Scanlan , et al. May 14, 2	2013-05-14
Method For Inducing Cell Lysis With Immunogenic Portions Of Ny-eso-1 Protein App 20120231035 - Knuth; Alexander ; et al.	2012-09-13
Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein Grant 8,142,786 - Knuth , et al. March 27, 2	2012-03-27
A34 And A33-like 3 Dna Protein, Antibodies Thereto And Methods Of Treatment Using Same App 20120039892 - Scanlan; Matthew ; et al.	2012-02-16
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 8,071,717 - Jager , et al. December 6, 2	2011-12-06
Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein App 20110182944 - Knuth; Alexander ; et al.	2011-07-28
Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein Grant 7,888,100 - Knuth , et al. February 15, 2	2011-02-15
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20100278850 - Jager; Dirk ; et al.	2010-11-04
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof Grant 7,795,409 - Jager , et al. September 14, 2	2010-09-14
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 7,622,568 - Jager , et al. November 24, 2	2009-11-24
A34 And A33-like 3 Dna Protein, Antibodies Thereto And Methods Of Treatment Using Same App 20090263394 - Scanlan; Matthew ; et al.	2009-10-22
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof App 20090203123 - Jager; Dirk ; et al.	2009-08-13
A34 and A33-like 3 DNA, proteins, antibodies thereto and methods of treatment using same Grant 7,521,543 - Scanlan, legal representative , et al. April 21,	2009-04-21
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20080177031 - Jager; Dirk ; et al.	2008-07-24
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 7,354,992 - Jager , et al. April 8, 2	2008-04-08
Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof Grant 7,291,335 - Stockert , et al. November 6, 2	2007-11-06
A34 and a33-Like 3dna, proteins, antibodies thereto and methods of treatment using same App 20060292154 - Scanlan; Matthew ; et al.	2006-12-28
Isolated peptides corresponding to amino acid requirements of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof App 20060269960 - Knuth; Alexander ; et al.	2006-11-30
Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses Grant 7,132,507 - Jager , et al. November 7, 2	2006-11-07
Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 Grant 7,115,729 - Knuth , et al. October 3, 2	2006-10-03
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,911,529 - Jager , et al. June 28, 2	2005-06-28
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20050063981 - Jager, Dirk ; et al.	2005-03-24
Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 App 20040158044 - Knuth, Alexander ; et al.	2004-08-12
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,774,226 - Jager , et al. August 10, 2	2004-08-10
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20040126398 - Jager, Dirk ; et al.	2004-07-01
Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof Grant 6,723,832 - Knuth , et al. April 20, 2	2004-04-20
Truncated forms of NY-ESO-1 protein Grant 6,525,177 - Stockert , et al. February 25, 2	2003-02-25
Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses App 20030017547 - Jager, Dirk ; et al.	2003-01-23
Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof App 20020164665 - Stockert, Elisabeth ; et al.	2002-11-07
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,448,073 - Jager , et al. September 10, 2	2002-09-10
Truncated forms of NY-ESO-1 protein App 20020010321 - Chen, Yao-tseng ; et al.	2002-01-24
Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof Grant 6,274,145 - Chen , et al. August 14, 2	2001-08-14
Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof Grant 6,069,233 - Chen , et al. May 30, 2	2000-05-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.